Skip to content
Gliclazide
Gliclazide is a small molecule pharmaceutical. It is currently being investigated in clinical studies.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
A: Alimentary tract and metabolism drugs
— A10: Drugs used in diabetes
— A10B: Blood glucose lowering drugs, excl. insulins
— A10BB: Sulfonylureas for blood glucose lowering
— A10BB09: Gliclazide
HCPCS
No data
Clinical
Clinical Trials
42 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Type 2 diabetes mellitusD003924EFO_0001360E1111519531
Diabetic nephropathiesD003928EFO_0000401———1—1
Non-alcoholic fatty liver diseaseD065626EFO_0003095K75.81———1—1
Metabolic bone diseasesD001851HP_0000938———1—1
OsteoporosisD010024EFO_0003882M81.0———1—1
MenopauseD008593EFO_0003922N95———1—1
Angina pectorisD000787EFO_0003913I20———1—1
Indications Phases 3
No data
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
PsoriasisD011565EFO_0000676L40—1———1
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Healthy volunteers/patients—3————3
EpilepsyD004827EFO_0000474G40.91————1
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Diabetes mellitusD003920EFO_0000400E08-E13————11
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameGLICLAZIDE
INNgliclazide
Description
Gliclazide is a N-sulfonylurea. It has a role as a hypoglycemic agent, a radical scavenger and an insulin secretagogue.
Classification
Small molecule
Drug classantidiabetics
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
Cc1ccc(S(=O)(=O)NC(=O)NN2CC3CCCC3C2)cc1
Identifiers
PDB—
CAS-ID21187-98-4
RxCUI4816
ChEMBL IDCHEMBL427216
ChEBI ID31654
PubChem CID3475
DrugBankDB01120
UNII IDG4PX8C4HKV (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 4,612 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
1,161 adverse events reported
View more details